This special series of the Governing Health podcast, presented in collaboration with SullivanCotter, explores key developments and provides guidance for boards’ executive compensation committees as they navigate complex operational, technical, and strategic challenges. In this episode, Michael Peregrine, Kerrin Slattery, and Jeff Holdvogt examine why innovative compensation incentives have become a pressing topic for health systems and their compensation committees.
Compensation considerations for health system innovation activities
Posted In Executive Compensation
Michael W. Peregrine represents corporations, their boards of directors, and individual directors and officers in connection with the full range of governance, fiduciary duty, director liability and leadership issues. Much of Michael’s practice involves advising boards of directors on matters of sensitivity and controversy, often in connection with corporate and fiduciary crises. He is recognized as one of the leading national corporate governance counselors and is a respected interpreter of the law of fiduciary duties.Read Michael W. Peregrine's full bio.
With a diverse transaction practice focused on hospitals, health systems, investors and other healthcare industry participants throughout the country, Kerrin B. Slattery has earned a reputation for excellence. Her significant experience across a wide range of health industry transactions, including mergers, acquisitions, affiliations, joint ventures and system restructurings involving nonprofit hospitals and health systems, academic medical centers, post-acute providers, large medical groups and their investors, makes her a valuable partner to healthcare leaders working to implement strategy, drive innovation and operate in a highly-regulated and rapidly evolving landscape. Read Kerrin Slattery's full bio.
Jeffrey (Jeff) M. Holdvogt regularly counsels public and privately held companies and tax-exempt organizations on a wide range of employee benefits matters. These include the design and administration of complex pension, 401(k) and 403(b) plans, nonqualified and executive deferred compensation arrangements, fiduciary and plan investment issues under the Employee Retirement Income Security Act (ERISA), internal compliance reviews and voluntary correction filings, and benefit plan matters arising from mergers and acquisitions, as well as other ongoing day-to-day retirement and executive compensation issues. Read Jeff Holdvogt's full bio.
Related Posts
- How the Tax Act Upsets the Board/Executive Compensation Committee Dynamic
- Governing Health Podcast | 2025 Executive Compensation Committee: Key Priorities and Strategic Insights
- Addressing DOJ’s New Compliance Focus on Executive Compensation
- Insights and Challenges for the Executive Compensation Committee
- Tax Reform Bill Becomes Law: Lessons for Tax-Exempt Organizations
BLOG EDITORS
STAY CONNECTED
TOPICS
ARCHIVES
RECENT POSTS
- Compensation considerations for health system innovation activities
- IRS issues FAQs addressing Employee Retention Credits under OBBBA
- EEOC enforcement actions underscore employers’ religious accommodation policies
- Government shutdown continues as start of ACA open enrollment approaches
- Layoffs and rightsizing for unionized or unionizing workforces

